Technetium Tc-99m Teboroxime Kit Patent Expiration
Technetium Tc-99M Teboroxime Kit was first introduced by Bracco Diagnostics Inc
Technetium Tc-99m Teboroxime Kit Patents
Given below is the list of patents protecting Technetium Tc-99m Teboroxime Kit, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cardiotec | US6056941 | Kit for the preparation of technetium TC 99m teboroxime myocardial perfusion agent |
Jul 28, 2019
(Expired) | Bracco |
Technetium Tc-99m Teboroxime Kit's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List